The group of alarmins (HGMB1, IL‐1α, S100 proteins and IL‐33) showed a different role, promoting or inhibiting tumour progression, depending on the type of the tumour, stage and their localization.2, 3. This evidence concerns the gene IL1A and neoplasm.